Unknown

Dataset Information

0

Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua.


ABSTRACT: Sustained expression of therapeutic factor IX (FIX) levels has been achieved after adeno-associated viral (AAV) vector-based gene therapy in patients with hemophilia B. Nevertheless, patients are still at risk of vector dose-limiting toxicity, particularly liver inflammation, justifying the need for more efficient vectors and a lower dosing regimen. A novel increased potency FIX (designated as CB 2679d-GT), containing 3 amino acid substitutions (R318Y, R338E, T343R), significantly outperformed the R338L-Padua variant after gene therapy. CB 2679d-GT demonstrated a statistically significant approximately threefold improvement in clotting activity when compared with R338L-Padua after AAV-based gene therapy in hemophilic mice. Moreover, CB 2679d-GT gene therapy showed significantly reduced bleeding time (approximately fivefold to eightfold) and total blood loss volume (approximately fourfold) compared with mice treated with the R338L-Padua, thus achieving more rapid and robust hemostatic correction. FIX expression was sustained for at least 20 weeks with both CB 2679d-GT and R338L-Padua whereas immunogenicity was not significantly increased. This is a novel gene therapy study demonstrating the superiority of CB 2679d-GT, highlighting its potential to obtain higher FIX activity levels and superior hemostatic efficacy following AAV-directed gene therapy in hemophilia B patients than what is currently achievable with the R338L-Padua variant.

SUBMITTER: Nair N 

PROVIDER: S-EPMC8191862 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8130854 | biostudies-literature
| S-EPMC6029626 | biostudies-literature
| S-EPMC6834974 | biostudies-literature
| S-EPMC6675543 | biostudies-literature
| S-EPMC6039963 | biostudies-literature
| S-EPMC4278802 | biostudies-literature
| S-EPMC5987250 | biostudies-literature
| S-EPMC7948292 | biostudies-literature
| S-EPMC6141116 | biostudies-literature
| S-EPMC5833265 | biostudies-literature